Randomisierte kontrollierte Studie
Concerns regarding intranasal midazolam versus mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial
Epilepsia · 20.11.2026
DOI: 10.1002/epi.70597 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Epilepsia, online erschienen am 20.11.2026. Verfasst von Rupali Bavikar und 1 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bavikar, R., & Kulkarni, R. (2026). Concerns regarding intranasal midazolam versus mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial. Epilepsia. https://doi.org/10.1002/epi.70597
Vancouver
Bavikar R, Kulkarni R. Concerns regarding intranasal midazolam versus mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial. Epilepsia. 2026. doi:10.1002/epi.70597
BibTeX
@article{Bavikar2026,
author = {Bavikar, Rupali and Kulkarni, Rajesh},
title = {Concerns regarding intranasal midazolam versus mouth‐dissolving clobazam in terminating seizures: A randomized controlled trial},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70597}
}
EUVIMED